NCT00091377 - Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Interventions

DRUG

cisplatin

IV 40 mg/m2 on Day 2 Number of Cycles: until progression or unacceptable toxicity or other withdrawal criteria are met.

DRUG

paclitaxel

IV 80 mg/m2 on Day 2 Number of Cycles: until progression or unacceptable toxicity or other withdrawal criteria are met.

DRUG

phenoxodiol

IV 3 mg/kg

Trial Locations (2)

Royal Women's Hospital, Carlton

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven